Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::CHANGE OF DIRECTOR'S INTEREST - DR TAN KIA KING

Issuer & Securities

Issuer/ Manager
HYPHENS PHARMA INTERNATIONAL LIMITED
Securities
HYPHENS PHARMA INTL LIMITED - SG1EE4000006 - 1J5
Stapled Security
No

Announcement Details

Announcement Title
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer
Date &Time of Broadcast
03-Dec-2021 18:03:26
Status
New
Announcement Sub Title
CHANGE OF DIRECTOR'S INTEREST - DR TAN KIA KING
Announcement Reference
SG211203OTHRJDA4
Submitted By (Co./ Ind. Name)
Lim See Wah
Designation
Executive Chairman and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
Please refer to attach Form 1.

This announcement has been reviewed by the Company's sponsor, SAC Capital Private Limited (the "Sponsor"). This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Lee Khai Yinn (Tel: (65) 6232 3210) who can be contacted at 1 Robinson Road, #21-00 AIA Tower, Singapore 048542.

Additional Details

Person(s) giving notice
Director/Chief Executive Officer who may also be a substantial shareholder/unitholder (Form 1)
Date of receipt of notice by Listed Issuer
03/12/2021

Attachments

eFORM1V2 - TKK_031221_final.pdf
if you are unable to view the above file, please click the link below.
_eFORM1V2 - TKK_031221_final.pdf
Total size =150K